Successfully navigating cell and gene therapy supply chains in the post-pandemic world

Cell and gene therapy supply chains have dealt with significant impacts from the COVID-19 pandemic, leading to questions of  shipping efficiency, transparency and certainty.

LP 496 px

 

In the latest Insight from Biocair you will learn about:

  • How COVID-19 has impacted the cell and gene therapy supply chain management
  • How to deal with the airfreight shortage
  • The role of packaging for an unbroken cold chain